A carregar...
Thymosins in multiple sclerosis and its experimental models: moving from basic to clinical application
Background: Multiple sclerosis (MS) afflicts more than 2.5 million individuals worldwide and this number is increasing over time. Within the past years, a great number of disease-modifying treatments have emerged; however, efficacious treatments and a cure for MS await discovery. Thymosins, soluble...
Na minha lista:
| Publicado no: | Mult Scler Relat Disord |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier B.V.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7104151/ https://ncbi.nlm.nih.gov/pubmed/30317071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2018.09.035 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|